Active Ingredient (In Each Dose)
Polyethylene Glycol 3350, 17 g (cap filled to line)
The following Structured Product Label (SPL) was submitted to the FDA by Padagis Israel Pharmaceuticals Ltd for the product Polyethylene Glycol 3350 (NDC 45802-868). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each dose), purpose, use, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Polyethylene Glycol 3350, 17 g (cap filled to line)
Osmotic Laxative
Allergy alert: Do not use if you are allergic to polyethylene glycol
if you have kidney disease, except under the advice and supervision of a doctor
taking a prescription drug
you may have loose, watery, more frequent stools
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
none
1-800-719-9260
Compare to MiraLAX® active ingredient
Polyethylene Glycol 3350
Powder for Solution
Osmotic Laxative
Relieves Occasional Constipation/Irregularity
Softens Stool
Unflavored Powder
Grit Free
NET WT 8.3 OZ (238 g)
14 Once-Daily Doses
* Please review the disclaimer below.